Future of Pharmacy

Artificial intelligence (AI) is transforming drug development by automating routine tasks, enhancing clinical trials, and expediting drug discovery, ultimately leading to more personalized treatments.

It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.

Alan Corley, pharmacy owner in Greenville, TN, reflects on the changes he's witnessed throughout his career and the most rewarding aspects of his profession.

As the end of this Congress approaches, the National Community Pharmacists Association is lobbying members to pass pharmacy benefit manager reforms.

Shifting from a vertical, isolated care model into a collaborative approach can improve the clinician and patient experience.

Three of the largest pharmacy benefit managers ––Express Scripts, Optum, and Caremark––are listed in the suit.

With the end of the PREP Act provisions approaching, we want to understand how pharmacists feel about their scopes of practice in each state, and what they think about the future of the profession.

Incorporating AI into pharmacy education is crucial to training on its appropriate use.

Fred Barton discusses the role of PBMs in making prescription drug decisions.

High-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.

Eight areas of improvement were developed as part of national initiative with stakeholder involvement.

For pharmacies, AI and other technologies are key to thriving in the era of value-based care.

In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.

When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.

The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.

In a session at NACDS Total Store Expo, experts spoke to the success of value-based care models in the pharmaceutical industry.

Sara Roszak discusses her role as president of the NACDS Foundation.

Scott Biggs and Doug Long explain current trends in the pharmaceutical industry and the importance of ensuring pharmacists are informed.

Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

A federal and state policy expert discusses the announcement from the Centers for Medicare & Medicaid Services on the agreement to lower prices for 10 selected drugs due to the Inflation Reduction Act.

The FDA also granted rare pediatric disease designation for the drug.

Chris Peshek of Discount Drug Mart discusses the importance of community pharmacies and the process of building relationships with patients, and how a profession in the field can be rewarding for those seeking to pursue it.

Customers report that their communication is strong with their pharmacists, but only 51% said their pharmacist was trustworthy.

Tune into this episode of “Public Health Matters” to hear a discussion with Dr. Frank North centered around successful mentorship and advocacy for representation across minority groups in the pharmacy profession.